SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 16th, 2022 • Adhera Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 16th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May ___, 2022, by and between Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITY AGREEMENTSecurity Agreement • May 16th, 2022 • Adhera Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 16th, 2022 Company IndustryThis SECURITY AGREEMENT, dated as of May __, 2022 (this “Agreement”), is among Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), all of the subsidiaries of the Company (such subsidiaries, the “Guarantors” and together with the Company, the “Debtors”) and the holders of the Company’s Original Issue Discount Senior Secured Promissory Notes (collectively, the “Notes”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”).
COMMON STOCK PURCHASE WARRANTAdhera Therapeutics, Inc. • May 16th, 2022 • Pharmaceutical preparations
Company FiledMay 16th, 2022 IndustryTHIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ , or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fifth year six month anniversary (October __, 2027) of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), up to ___________ shares of Common Stock (subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant issued pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) entered into as of the Initial Exercise Date between the Company and the initial Holder.
original issue discount SENIOR SECURED PROMISSORY NOTEAdhera Therapeutics, Inc. • May 16th, 2022 • Pharmaceutical preparations
Company FiledMay 16th, 2022 IndustryTHIS ORIGINAL ISSUE DISCOUNT SENIOR SECURED PROMISSORY NOTE is duly authorized and validly issued at an original issue discount by ADHERA THERAPEUTICS, INC., a Delaware corporation (the “Company”) (this “Note”).